Implanon Discontinuation Rate and It's Associated Factors in Debre Tabor Town, North Central Ethiopia

Abstract

Family planning could avert a significant number of maternal mortality and contributes to child survival with its focus on women's rights. Generally, a long-acting reversible contraceptive is more effective and cover all the advantage and eliminates the disadvantages of other types of contraceptives. The acceptance and utilization of long-acting reversible contraceptive including implanon were very low in many developing countries including Ethiopia. The purpose of this study was to assess the level of discontinuation and to identify variables influencing Implanon utilization. A cross-sectional design was conducted between January to December 2018 in Debre Tabor town. In the community, a total of 132 women who have been using or discontinuing Implanon during the study period were selected. Face-to-face interviews using a structured questionnaire were conducted for data collection. The data were entered, cleaned and analyzed by a statistical package for social sciences version 20. The data were processed and analyzed by a statistical package for social sciences version 20 using descriptive and analytical statistics including chi-square test that identified the association between some selected independent variables and implanon discontinuation. The overall implanon discontinuation in the year 2018 was 16.7% in Debre Tabor town. The most frequently mentioned reason for implanon discontinuation was health-related issues (31.8%), side effects (27.3%), desire to have more children (22.7%) and method shift (18.2%). Factors associated with Implanon discontinuation were developing side effects, women who have living children and not providing counseling service. Implanon discontinuation among Implanon users in Debre Tabor town during the year 2018 was found to be high and the most frequently mentioned rationale was health-related issues. Health care providers should provide counseling before Implanon insertion.

The prevalence of Implanon discontinuation and associated factors among Ethiopian women: A systematic review and meta-analysis

“…The publication year ranged from 2015 to 2021. The minimum and the maximum sample sizes were 132 and 711, which were obtained from studies conducted in Amhara 34 and South Nations, Nationalities, and Peoples’ Region (SNNPR), 36 respectively. Regarding the distribution of studies across the geographic region of the country, four were from the Amhara region, 28,34,35,37 three were from the Oromia region, 28,29,33 two were from Tigray, 32,38 and two were from SNNPR 31,36 (Table 1).…”

“…A total of 11 cross-sectional studies were included in this systematic review and meta-analysis. [28][29][30][31][32][33][34][35][36][37][38] A total of 4320 Implanon users were considered in the meta-analysis. In all of the studies, data were collected by a face-to-face interview using a pre-tested, interviewer-administered questionnaire.…”

Prevalence of contraceptive implant discontinuation among women who used implant in Ethiopia: Systemic review and meta-analysis

“…All studies included in this meta-analysis were published between 2015 and 2022. A total of 5012 women who were using contraceptive implants were participated in the analysis, with a minimum sample size of 134 16 and maximum of 711. 17 From 13 articles included in this systematic review and meta-analysis, only four regions of Ethiopia were identified.…”

“…17 From 13 articles included in this systematic review and meta-analysis, only four regions of Ethiopia were identified. Of the total studies included, four were conducted in Amhara; 16,[18][19][20] four in South Nations Nationalities and Peoples of Ethiopia national (SNNPR), 17,[21][22][23] three studies in Oromia [24][25][26] and two in Tigray. 27,28 Six studies were conducted in urban areas and the rest seven were conducted in rural areas.…”

“…To date, the prevalence of implant discontinuation rate in Ethiopia ranges from 16% to 66%. [16][17][18][19][20][21][22][23][24][25][26][27][28] However, those studies offered district-level information and there is no updated national representative evidence regarding the overall discontinuation rate about all types of implant contraceptives. So it is practical to work on synthesizing the evidence.…”